Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 12
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07251153 | Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions | ||
| NCT03272009 | Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects | ||
| NCT03320616 | EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT03110276 | Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects | ||
| NCT04037618 | Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose | ||
| NCT03469583 | Drug Drug Interaction Study for EYP001 With Entecavir | ||
| NCT04465916 | Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD) | ||
| NCT06939816 | Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis) | ||
| NCT03812029 | Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) | ||
| NCT04365933 | A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir | ||
| NCT03976687 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients | ||
| NCT06425055 | Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1) |
